Back to the Xenexus Pharmaceutical Home Page


Xenexus Pharmaceuticals - Developing innovative drugs for the treatment of neurological disorders Xenexus Pharmaceuticals - Developing innovative drugs for the treatment of neurological disorders Xenexus Pharmaceuticals - Developing innovative drugs for the treatment of neurological disorders Xenexus Pharmaceuticals - Developing innovative drugs for the treatment of neurological disorders

Management

Dr Michael L. Selley, PhD, FRACI

Chief Executive Officer


Dr Michael L. Selley - Chief Executive Officer

Dr Selley has considerable experience in pharmaceutical research and development. He was the founder and Chief Scientific Officer of Nuon Therapeutics, Inc. in San Mateo, California, U.S.A. and the founder of Angiogen Pharmaceuticals Pty. Ltd. and Xenexus Pharmaceuticals Pty. Ltd. in Sydney Australia. Dr Selley served as Chief of Staff to the Minister for Science and Technology in the Parliament of Australia and held academic appointments in the John Curtin School of Medical Research at the Australian National University. He has worked in the international pharmaceutical industry in a number of roles, including drug discovery and clinical pharmacology.

Robert J. Scott, MBA

Chief Operating Officer

Robert Scott has nearly 20 years' experience in delivering trade, transaction and advisory services to pharmaceutical and medical technology companies entering China. His specialist areas include mergers and acquisitions, business planning and raising venture capital.

Dr Scott L. Friedman, M.D.

Consultant

Dr Scott L. Friedman is the Dean for Therapeutic Discovery and Chief of the Division of Liver Diseases, at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. Dr Friedman was among the first to isolate and characterise the hepatic stellate cell, the key cell type responsible for scar production in liver.






by Echidna Web Design. Click here to visit.